EXCELLYSE I

The EXCELLYSE I (RUO) lysing solution is intended for red blood cell lysis following antibody staining of human peripheral blood leukocytes. The lysing solution is appropriate for use with EXBIO single colour monoclonal antibodies and KOMBITEST reagents and may be used in both lyse/wash and lyse/no wash protocol.

The content of the vial (100 mL) is sufficient for 500 - 1000 Tests. The lysing solution is ready to use.

*Klocperk A, Bloomfield M, Páráčková Z, Zentsová I, Vrabcová P, Balko J, Meseznikov G, Casas Mendez LF, Grandcourtová A, Šípek J, Tulach M, Zámečník J, Vymazal T and Šedivá A: Complex immunometabolic profiling reveals the activation of cellular immunity and biliary lesions in patients with severe COVID-19. J. Clin. Med. 2020, 9(9), 3000doi.org/10.3390/jcm9093000, URL: https://www.mdpi.com/2077-0383/9/9/3000,*Mráz M, Cinkajzlová A, Kloučková J, Lacinová Z, Kratochvílová H, Lipš M, Pořízka M, Kopecký P, Lindner J, Kotulák T, Netuka I, Haluzík M: Dendritic cells in subcutaneous and epicardial adipose tissue of subjects with type 2 diabetes, obesity, and coronary artery disease. Mediators Inflamm. 2019 May 92019:5481725. , URL: https://pubmed.ncbi.nlm.nih.gov/31210749/,*Mráz M, Cinkajzlová A, Kloučková J, Lacinová Z, Kratochvílová H, Lipš M, Pořízka M, Kopecký P, Pierzynová A, Kučera T, Melenovský V, Stříž I, Lindner J, Haluzík M: Coronary artery disease is associated with an increased amount of T lymphocytes in human epicardial adipose tissue. Mediators Inflamm. 2019 Feb 72019:4075086., URL: https://pubmed.ncbi.nlm.nih.gov/30881222/,*Cinkajzlová A, Lacinová Z, Kloučková J, Kaválková P, Trachta P, Kosák M, Krátký J, Kasalický M, Doležalová K, Mráz M, Haluzík M: An alternatively activated macrophage marker CD163 in severely obese patients: The influence of very low-calorie diet and bariatric surgery. Physiol Res. 2017 Sep 2266(4):641-652. , URL: https://pubmed.ncbi.nlm.nih.gov/28406702/,*Novák P, Schmidt R, Kontseková E, Kovacech B, Smolek T, Katina S, Fialová L, Prcina M, Parrak V, Dal-Bianco P, Brunner M, Staffen W, Rainer M, Ondrus M, Ropele S, Smíšek M, Sivák R, Žilka N, Winblad B, Novák M: FUNDAMANT: An interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease. Alzheimers Res Ther. 2018 Oct 2410(1):108., URL: https://pubmed.ncbi.nlm.nih.gov/30355322/,*Faulhaber F, Faulhaber GA, Marcondes N, Procianoy R, Silveira RC: Expression of neutrophil surface markers in icteric neonates before and after phototherapy. Cytometry B Clin Cytom. 2018 Nov94(6):895-900., URL: https://pubmed.ncbi.nlm.nih.gov/30294859/,

*PH Carter, S Resto-Ruiz, GC Washington, S Ethridge, A Palini, R Vogt, M Waxdal, T Fleisher, PD Noguchi, GE Marti: Flow cytometric analysis of whole blood lysis, three anticoagulants, and five cell preparations, Cytometry 13:68-74 (1992). Wiley-Liss, Inc. 1992. , URL: https://www.ncbi.nlm.nih.gov/pubmed/?term=Flow+cytometric+analysis+of+whole+blood+lysis%2C+three+anticoagulants%2C+and+five+cell+preparations,*KR Tamul, JL Schmitz, K Kane, and JD Folds: Comparison of the effects of Ficoll-Hypaque separation and whole blood lysis on results of immunophenotypic analysis of blood and bone marrow samples from patients with hematologic malignancies, Clin. Diagn. Lab. Immunol. 1995 May 2(3): 337–342., URL: https://www.ncbi.nlm.nih.gov/pubmed/?term=Comparison+of+the+effects+of+Ficoll-Hypaque+separation+and+whole+blood+lysis+on+results+of+immunophenotypic+analysis+of+blood+and+bone+marrow+samples+from+patients+with+hematologic+malignancies,